0.67
-0.0428(-5.98%)
Currency In USD
| Previous Close | 0.72 |
| Open | 0.71 |
| Day High | 0.72 |
| Day Low | 0.67 |
| 52-Week High | 2.06 |
| 52-Week Low | 0.52 |
| Volume | 1.71M |
| Average Volume | 3.82M |
| Market Cap | 196.36M |
| PE | -3.36 |
| EPS | -0.2 |
| Moving Average 50 Days | 0.65 |
| Moving Average 200 Days | 0.91 |
| Change | -0.04 |
If you invested $1000 in Ocugen, Inc. (OCGN) 10 years ago, it would be worth $1.36 as of May 07, 2025 at a share price of $0.672. Whereas If you bought $1000 worth of Ocugen, Inc. (OCGN) shares 5 years ago, it would be worth $2,037.58 as of May 07, 2025 at a share price of $0.672.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
GlobeNewswire Inc.
May 02, 2025 12:00 PM GMT
MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress
GlobeNewswire Inc.
Apr 29, 2025 11:30 AM GMT
MALVERN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifi
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
GlobeNewswire Inc.
Apr 08, 2025 12:02 PM GMT
MALVERN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive O